WisBusiness: The head of a Milwaukee pharmaceutical firm called Estrigenix Therapeutics says the company has raised $1.7 million as it develops alternative menopause therapies

Speaking during this week’s Early Stage Symposium, held in Madison by the Wisconsin Technology Council, company President and CEO William Donaldson described existing hormone replacement therapies for menopause as a “double-edged sword.” He explained that while HRT...